glp-1 super responders Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of Analogues in Obesity Management: A Longitudinal Prospective Cohort Study GLP-1 Super Responder? 116 lb

This insight should be interpreted with your qualified healthcare provider and can support a more personalized conversation about whether Ozempic or alternative GLP-1 formulations suit your metabolic profile

C., Patchva S., Aggarwal B

The honest summary: Retatrutide probably does produce modestly greater weight loss than tirzepatide at maximum doses, potentially in the range of 36 percentage points of body weight

GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy

doi: 10.1016/J.BCP.2020.114187